All posts by: Michael Zand

About Michael Zand

Gene Therapy Offers New Hope To Leukemia Patients At Cincinnati Children’s – WOSU Public Media

Continue reading

2017-10-09 NEWS

WOSU Public Media

Gene Therapy Offers New Hope To Leukemia Patients At Cincinnati Children’s
WOSU Public Media
Gene therapy is showing promise in other formers of cancer. Melanoma and brain cancer are among cancers where immunotherapy is an option. Javier El-Bietar, a bone marrow transplant doctor at Children’s is optimistic about Kymriah for ALL patients.

and more »

Continue reading

2017-10-09 NEWS

OncLive

Immunotherapy for Management of Stage 3B NSCLC
OncLive
Everett Vokes, MD: At this point, we should move on and talk a little bit about earlier stage disease and how therapies are developing. This year, at The European Society for Medical Oncology (ESMO) 2017 Congress, in particular, we’ve received new …

Continue reading

2017-10-09 NEWS

Immunotherapy in Liver Cancer
OncLive
Arndt Vogel, MD: Immunotherapy is great, at least we assume that it’s really great. But—and this is unfortunately a “but” that is getting bigger and bigger. Actually, we have seen very promising data with nivolumab. And I think patients who respond to …

Continue reading

2017-10-09 NEWS

OutSourcing-Pharma.com

FDA aims to better understand immunotherapy in the ‘real world’
OutSourcing-Pharma.com
However, following FDA-approval of immunotherapies to treat various cancer, Kush explained the agency “wishes to better understand the safety effects of such drugs in the ‘real world,’ in addition to safety data from clinical trials​.” To do so, the US